Serum levels of soluble Fas ligand in patients with silicosis

Por Tomokuni, A, Otsuki, T, Isozaki, Y, Kita, S, Ueki, H, Kusaka, M, Kishimoto, T, Ueki, A
Publicado em 1999

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours

Por TOMOKUNI, A, AIKOH, T, MATSUKI, T, ISOZAKI, Y, OTSUKI, T, KITA, S, UEKI, H, KUSAKA, M, KISHIMOTO, T, UEKI, A
Publicado em 1997

Soluble Fas mRNA is dominantly expressed in cases with silicosis.

Por Otsuki, T, Sakaguchi, H, Tomokuni, A, Aikoh, T, Matsuki, T, Kawakami, Y, Kusaka, M, Ueki, H, Kita, S, Ueki, A
Publicado em 1998

Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individu...

Por Ueki, A, Isozaki, Y, Tomokuni, A, Hatayama, T, Ueki, H, Kusaka, M, Shiwa, M, Arikuni, H, Takeshita, T, Morimoto, K
Publicado em 2002

Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients

Por Otsuki, T, Tomokuni, A, Sakaguchi, H, Aikoh, T, Matsuki, T, Isozaki, Y, Hyodoh, F, Ueki, H, Kusaka, M, Kita, S, Ueki, A
Publicado em 2000

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

Por Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M
Publicado em 2010

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

Por Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Publicado em 2013